Tech Company Financing Transactions
Sarepta Therapeutics Funding Round
Bank of America, Barclays and Fifth Third Bank participated in a $600 million venture round for Sarepta Therapeutics. This venture round closed on 2/17/2025.
Transaction Overview
Company Name
Announced On
2/17/2025
Transaction Type
Venture Equity
Amount
$600,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to allocate the amount to expand operations and its R&D efforts.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
215 1st St.
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Sarepta Therapeutics, Inc., (NASDAQ: SRPT) a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Douglas Ingram
Chief Financial Officer
Sandesh Mahatme
Chief Medical Officer
Gilmore O'Neill
VP - Bus. Development
Bo Cumbo
VP - General Counsel
Ty Howton
VP - Human Resources
Joan Nickerson
VP - Regulatory Affairs
Diane Berry
VP - Regulatory Affairs
Gary Charbonneau
VP - Regulatory Affairs
Ian Estepan
Browse more venture capital transactions:
Prev: 2/17/2025: Finalrentals venture capital transaction
Next: 2/17/2025: Udaan venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs